Sfoglia per Autore
La terapia metabolica nel trattamento dell'ischemia critica cronica degli arti inferiori: la L-propionilcarnetina potenzia gli effetti della PGE-1
2004-01-01 MILIO G; GENOVA C; AMATO C; RAIMONDI F; NOVO S
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis
2004-01-01 MALATO A; ANASTASIO R; MILIO G; BONIFACIO G; PELLEGRINO M; SIRAGUSA S
Calf vein thrombosis: optimal duration of treatment
2004-01-01 FERRARA F; CAIMI G; MELI F; AMATO C; COSPITE V; MILIO G; RAIMONDI F; NOVO S
Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism
2004-01-01 Milio G, Amato C, Siragusa S, Cospite V, Cospite M, Pinto A, Novo S
MTHFR allele 677T band risk of abdominal aortic aneurysm
2004-01-01 FERRARA F; CAIMI G; MELI F; AMATO C; COSPITE V; MILIO G; RAIMONDI F; NOVO S
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT
2004-01-01 SIRAGUSA S; MILIO G; ANASTASIO R; MALATO A; CORMACI O; AMATO C; PELLEGRINO M; MARIANI G
Calf vein thrombosis: optimal duration of tretment
2004-01-01 FERRARA F; CAIMI G; MELI F; AMATO C; COSPITE V; MILIO G; RAIMONDI F; NOVO S
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis
2004-01-01 MALATO A; ANASTASIO R; BONIFACIO G; PELLEGRINO M; MILIO G; SIRAGUSA S
Ischemia critica cronica e vasculopatia ischemica polidistrettuale
2004-01-01 MILIO G; COPPOLA G; GENOVA C
Critical limb ischaemia: definition and natural hystory
2004-01-01 NOVO S; COPPOLA G; MILIO G
Calf veins thrombosis: optimal duration of treatment
2004-01-01 FERRARA F; CAIMI G; MELI F; AMATO C; COSPITE V; MILIO G; RAIMONDI F; NOVO S
Subclavean stenosis/occlusion in patients with subclavean steal and previous by pass of internal mammary interventricular anterior artery: medical or surgery treatment?
2004-01-01 FERRARA F; MELI F; RAIMONDI F; MILIO G; AMATO C; COSPITE V; COSPITE M; NOVO S
Metabolic therapy in the treatment of chronic critical limbs ischemia: the L-propionyl-carnitine enhances the effects of PGE-1
2005-01-01 MILIO G; NOVO G; GENOVA C; AMATO C; RAIMONDI F; GOTTBERG M; NOVO S
THE EFFECTS OF PROSTAGLANDIN E-1 IN PATIENTS WITH INTERMITTENT CLAUDICATION
2005-01-01 MILIO G; COPPOLA G; NOVO S
TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI
2005-01-01 MILIO G; MIN C; AMATO C; SIRAGUSA S; NOVO S
Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici
2005-01-01 Milio G, Minà C, Amato C, Siragusa S, Novo S
Trattamento delle manifestazioni vascolari nella Sclerosi Sistemica e qualità della vita: nuovo protocollo
2005-01-01 MILIO G; CORRADO E; GENOVA C; AMATO C; RAIMONDI F; NOVO S
The effects Prostaglandine E-1 in patients with intermittent claudication
2005-01-01 MILIO G; COPPOLA G; NOVO S
SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS
2005-01-01 MILIO G; AMATO C; MIN C; SIRAGUSA S; NOVO S
METABOLIC THERAPY IN THE TREATMENT OF CHRONIC CRITICAL LIMBS ISCHEMIA OF THE LOWER LIMBS. THE L-PROPIONYL-CARNITINE ENHANCES THE EFFECTS OF PGE-1
2005-01-01 MILIO G; NOVO G; GENOVA C; AMATO C; RAIMONDI F; GOTTBERG M; NOVO S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile